Mortality in emphysematous pyelonephritis: Can we reduce it further by using a protocol-based treatment? The results of a prospective study



  Table of Contents ORIGINAL ARTICLE Year : 2022  |  Volume : 14  |  Issue : 1  |  Page : 73-80  

Mortality in emphysematous pyelonephritis: Can we reduce it further by using a protocol-based treatment? The results of a prospective study

Kalyanaram Kone, Naveen Thimiri Mallikarjun, MD R. K. Keerthi Rams
Department of Urology, Mahatma Gandhi Medical College, Puducherry, India

Date of Submission09-Oct-2020Date of Acceptance28-Mar-2021Date of Web Publication20-Jan-2022

Correspondence Address:
Dr. Naveen Thimiri Mallikarjun
7/77, AH Block, 5th Street, Anna Nagar, Chennai - 600 040, Tamil Nadu
India
Login to access the Email idCrossref citationsCheck

DOI: 10.4103/UA.UA_164_20

Rights and Permissions

   Abstract 


Introduction: Even though the mortality rate in emphysematous pyelonephritis (EPN) is brought down presently to 13%–25%, there is still scope for improvement. The hurdle lies in identifying those patients at risk of mortality earlier in the disease process and providing intensive management to them. In this study, we created risk groups by combining both clinical and radiological presentations and applied a protocol-based treatment to evaluate its role in reducing mortality.
Methods: We formulated a treatment protocol based on the available literature. The first step was to recruit all patients diagnosed with EPN into the treatment protocol as soon as possible without any delay. The second step was to stratify the patients into risk groups based on our clinicoradiological risk group classification. The third step was to apply the treatment protocol according to the risk group they belonged to.
Results: We treated 24 patients with EPN in the past 4 years. According to the radiological classification – four patients had Type 1 disease, five patients had Type 2A disease, six patients had Type 2B disease, four patients had Type 3A disease, two patients had Type 3B disease, two patients had Type 4A disease, and one patient had 4B disease. Following risk stratification, we have categorized seven patients into category 1, eight patients into category 2, and nine patients into category 3. All except one patient survived following the treatment protocol followed by us.
Conclusions: Early risk stratification, intensive management, and prompt treatment according to a protocol can reduce mortality even further in patients with EPN.

Keywords: Emphysematous pyelonephritis, golden day, mortality reduction, risk stratification, treatment protocol


How to cite this article:
Kone K, Mallikarjun NT, R. K. Keerthi Rams M D. Mortality in emphysematous pyelonephritis: Can we reduce it further by using a protocol-based treatment? The results of a prospective study. Urol Ann 2022;14:73-80
How to cite this URL:
Kone K, Mallikarjun NT, R. K. Keerthi Rams M D. Mortality in emphysematous pyelonephritis: Can we reduce it further by using a protocol-based treatment? The results of a prospective study. Urol Ann [serial online] 2022 [cited 2022 Jan 21];14:73-80. Available from: 
https://www.urologyannals.com/text.asp?2022/14/1/73/336161    Introduction Top

Emphysematous pyelonephritis (EPN) is a life-threatening necrotizing infection of the kidney characterized by production and accumulation of gas in the kidney and surrounding tissues.[1] From being a death sentence, the outcome of this life-threatening disease gradually improved in parallel with the improvements in imaging modalities, supportive care, and better understanding of the disease pathophysiology. The mortality rate of this disease gradually reduced from a historic high of 50% to around 13%–25% at present.[2],[3],[4],[5],[6] As with other areas of urology, with the reduction in mortality rate, the focus has shifted now from radical treatments toward nephron-sparing approach.[7]

At present, no one has second thoughts regarding initial treatment protocol – resuscitation, electrolyte management, rapid control of blood sugar levels, initiation of broad-spectrum antibiotics, emergency decompression of disease by either double J (DJ) stenting or percutaneous nephrostomy (PCN) or percutaneous drainage (PCD) along with judicious usage of early (EN) or delayed nephrectomy (DN). However, despite advances in the management, there still remained a group of patients who have a rapidly declining course. Wan et al. hypothesized that the difference in outcomes is probably related to the differences in severity of immune compromise and the vascular insufficiency in the kidneys.[8] Hence, the last hurdle in further reduction of mortality lies in identifying this group earlier in the disease process and providing them with intensive management.

However, crossing the last hurdle is not easy as there are some problems inherent in the management of this disease. The first problem is that the available case series on EPN were comprised of few patients and were retrospective in nature. It is very difficult to undertake large well-controlled studies in an uncommon and emergency disease condition. The second problem is that even after identifying the prognostic factors for mortality, there is still confusion prevailing as each study identified a different set of prognostic factors and there is no uniformity in them.[8],[9],[10],[11],[12],[13],[14],[15],[16],[17] The third problem is that even though the radiological classification (Wan's or Huang-Tseng's) used by most of the investigators gave an indication about the radiological severity of the disease, the clinical picture differed greatly among individuals with similar radiological presentation.[8],[9]

In this study, we have assimilated the data and interpretations from previously available studies and have applied them prospectively by combining early risk stratification factors to evolve a protocol-based treatment and assess whether these measures would help in further reduction of mortality. We will discuss our results in this study.

   Methods Top

We made a protocol-based treatment on the available literature with two distinct goals: the first one was reduction of mortality and the second one was organ preservation, wherever possible.[8],[9],[10],[11],[12],[13],[14],[15],[16],[17] The first step in the protocol was to recruit all the patients diagnosed with EPN into the treatment protocol as soon as possible without any delay. The principle was to treat the 1st day as Golden day just like the Golden hour in trauma. We made an observation that most of the deaths happened in patients admitted under other departments and later referred to us. The reason was that most of the patients presented with nonspecific symptoms and septic shock or multiorgan dysfunction were admitted in General Medicine or its allied specialties and by the time, the diagnosis was made, the patient would deteriorate further. The patients who consulted in the Urology Outpatient Department or referred directly to the Urology from casualty got immediate medical or surgical attention depending on their clinical and radiological picture. Hence, to reduce the delay in treatment, we had to sensitize the Casualty and our General Medicine colleagues regarding this clinical condition. In consultation with them, we made a protocol that all diabetic patients with unexplained fever and systemic symptoms should undergo noncontrast computed tomography (NCCT) kidney-ureter-bladder scan as soon as possible after initial stabilization. We have treated 104 patients with acute pyelonephritis over 4 years from January, 2016 to December, 2019, out of which, 24 patients were found to have EPN.

The second step was to classify these patients into risk groups [Table 1]. Group 1 comprised all stable patients with low-risk computed tomography (CT) findings. Group 2 comprised all stable patients with high-risk CT findings. Group 3 comprised all unstable patients irrespective of CT findings. The criteria for placing the patient in the stable/unstable category were based on the general condition and clinical picture of the patient [Table 2]. The risk factors identified were based on the previous research articles [Table 3].[8],[9],[10],[11],[12],[13],[14],[15],[16],[17]

Table 2: Criteria for placing the patient in stable/unstable category based on general condition and clinical profile of the patient Unstable – any one major or two minor criteria

Click here to view

Abdominal CT scan and echography were performed in all these cases. Modified Huang and Tseng classification was used to classify the radiological findings on the CT scan[9][Table 4]. Class 2 was subdivided into 2 groups – Class 2A and 2B in our study. 2A is with low volume gas in the kidney <3 cm in a single zone (upper, middle, or lower) and 2B is with high volume disease in the kidney with a cut-off value of 3 cm – >3 cm in a single zone or mottled gas appearance in multiple zones. This cut-off value was derived based on the renal abscess treatment protocol where we treat abscesses <3 cm with antibiotics. If there was mottling or streaky gas pattern, the whole intervening area (if it is nearby) was also included in calculating the volume. Class 4 was subdivided into 4A and 4B. Bilateral Class 1 was categorized as Class 4A. Class 1, 2A, and 4A were classified as low-risk CT findings and Class 2B, 3, and 4B were classified as high-risk CT findings. Hydronephrosis was defined as any dilatation of renal pelvis and calyces and was not accorded any specific risk.

Table 4: Risk categorization based on Modified Huang-Tseng radiological classification

Click here to view

The treatment protocol was formulated based on the various meta-analyses published previously [Table 5].[8],[9],[10],[11],[12],[13],[14],[15],[16],[17] The treatment algorithm is shown in [Table 6]. “Unsuccessful” treatment was defined as clinical manifestations of unstable hemodynamic parameters for 48 h, persistent fever of more than 100°F, and progressive or persistent lesions on further imaging studies. If there are progressive or persistent lesions on follow-up imaging, they were treated according to the original protocol.

   Results Top

We had diagnosed 25 patients with EPN in the past 4 years (from January, 2016 to December, 2019). One patient refused treatment and left the hospital before intervention. Hence, 24 patients were included in our study, and they were classified into three groups and treatment was given according to protocol. Patient demographics and characteristics are represented in [Table 7]. Age of the patients ranged from 32 years to 73 years. Twenty-one patients were diabetic. Blood glucose at presentation ranged from 188 to 512 mg/dL. Eighteen of the 21 diabetic patients had blood glucose more than 300 mg/dL at presentation. Most of the patients presented with flank pain and fever. The duration of symptoms ranged from 2 days to 1 month. Five patients admitted in medicine intensive care unit had nonspecific symptoms at presentation. Nine patients had features of obstructive uropathy because of necrosed papilla and two patients had obstructive uropathy because of urolithiasis. Nine patients had DJ stent placed and four had PCN placed in them.

Treatment of patients by risk categories is shown in [Table 8]. One patient had an interesting presentation. He had undergone PCD elsewhere at the time of initial presentation and presented to us with recurrent low-grade fever after 1 month. There was pus drainage from the drain after initial drainage of approximately 100 ml/day for 1 week. The kidney was auto-nephrectomized on NCCT with gas limited to the kidney. During nephrectomy, there was only a nubbin of kidney tissue left. Among the nine patients who belonged to Category 3, one patient had Type 2B disease on NCCT who had rapidly deteriorated despite bedside PCD. She was treated for 5 days elsewhere initially and presented to us with shock, delirium, and respiratory compromise.

All the patients had improved renal parameters following recovery. The improvement in creatinine ranged from 0.6 to 3.8. Twenty-two out of 24 patients had elevated creatinine at admission (>2 mg%) and four patients had creatinine more than 5 mg%.

   Discussion Top

Kelly and MacCallum first described about a gas-forming renal infection in 1898.[18] Since then, a variety of terms were used to describe this clinical condition – renal emphysema, pneumonephritis, pneumonephrogram, pyelonephritis emphysematosa, etc., Schultz and Klorfein suggested the term EPN as in their opinion, this stressed the importance between kidney infection and gas formation.[19] In 1941, Gillies and Flocks laid down three essential factors for gas production in the urinary tract – diabetes mellitus, obstructive uropathy, and gas-producing organisms.[20] Since then, the criteria that there should be obstructive uropathy are refuted by multiple reports. Now, the essential criteria are diabetes mellitus, obstructive uropathy, or both along with gas-producing organisms.

The initial investigators advised early aggressive surgical treatment in the form of emergency Nephrectomy, as they thought this might reduce mortality. Michaeli et al. presented data of 55 patients in 1984 and echoed the same sentiment[1] PN Klein et al. reviewed 66 reported cases of EPN in 1986 and found an overall mortality rate of 38%, i.e., 71% in medically treated patients and 29% in those surgically treated.[2] Others – Ahlering et al., Pontin et al., and Shokeir et al. – concluded that resuscitation and appropriate medical treatment should be attempted, but immediate nephrectomy should not be delayed, for the successful management of EPN.[3],[21],[22]

The whole scenario changed in 1986 with the report by Hudson et al., who first described fluoroscopically guided PCD for treating EPN, with successful clinical results.[23] However, this was slow to get accepted by the urology community. There was even a provocative article in 1993 by Koh et al., titled “emphysematous nephrectomy - drainage or nephrectomy” which still supported early nephrectomy (EN).[24] But with increasing reports of successful treatment of EPN with medical management and percutaneous drainage by multiple authors led many more urologists to question the role of emergency nephrectomy and adopt the nephron saving strategy in the treatment.[25],[26],[27],[28],[29]

With multiple authors reporting improved survival rates with PCD, the focus ultimately shifted from EN to salvaging the remaining kidney. Wan et al. reported their results of 38 patients and classified patients into 2 types: Type 1 – Dry type with mottled or streaky gas and Type 2 – wet type with fluid collections and bubbly or loculated gas.

The mortality in Type 1 was more than Type 2 (69% vs. 18%)[8],[30] Chen et al. (1997) published their 10-year results of 25 patients. Twenty patients became alright with antibiotics and PCD. Three patients required delayed nephrectomy and two patients died of septic shock. Importantly, gas pattern and the response to treatment had no correlation in their study.[31] Subsequently, Huang and Tseng published their clinicoradiological classification after analyzing the results of 48 patients.[31] Twenty seven out of 41 patients who had medical management along with PCD had successful outcome while rest underwent nephrectomy. Totally, nine out of 48 patients died with a mortality rate of 18.8%. According to CT findings, they classified patients into 4 groups and mortality rate had a direct correlation with the class. Following these reports, multiple authors validated the successful treatment with percutaneous drainage.[32],[33],[34],[35]

Meta-analysis by Mydlo et al. (160 patients) in 2003, Falagas et al. (175 patients) in 2007, and Somani et al. (210 patients) in 2008 firmly established the role of PCD in the treatment of this disease.[4],[10],[11] Somani et al. even went ahead and titled their article – Is PCD the new gold standard in the treatment of EPN.[4] Aswathaman et al. reported that those patients who were not nephrectomized maintained an average relative renal function of 42%.[7] Therefore, now it is established that the best treatment strategy should be the one that improves the patient survival and at the same time, maximizes the renal salvage. Finally, in 2014, Omar M. Aboumarzouk et al. published a review article calling for a proper management strategy.[6] They reviewed results of 628 patients and reported that the overall mortality rate was 18%. They also reported that shock was associated with a high mortality rate and therefore should be managed aggressively. PCD and medical management were associated with significantly higher survival rates than EN, and therefore, EN should only be considered if the patient does not improve despite other treatments. Along with authors prescribing early PCD, multiple reports also emerged advocating medical management alone for the treatment of EPN.[36],[37]

EPN can be compared to nontraumatic gas gangrene although the etiology and pathogenesis differ. The gas isolated in both conditions is similar, containing hydrogen, carbon dioxide, nitrogen in large quantities, and oxygen in small quantities – implying that the bacteria are indulging in mixed acid fermentation.[8],[9],[38],[39],[40] EPN is the interplay of high tissue glucose levels, impaired tissue perfusion, and weak immune system along with obstructive uropathy in some patients. At what point, acute pyelonephritis becomes EPN is not clear.

Almost all the published reports were case series and retrospective in nature. They identified a group of risk factors in the group of patients succumbing to the disease. However, different authors reported different risk factors. We selected a group of risk factors which were reported by majority of the authors and applied it together toward a prospective management plan. Many recent studies also claimed that the mortality is higher in the emergency nephrectomy group compared to the group of patients who underwent percutaneous drainage. However, the problem with this data is that the patients who underwent emergency nephrectomy were either very sick or underwent late nephrectomy. Most of these patients have multiple comorbidities and were at the extreme end of the sepsis spectrum. At what point of time, we have to resort to emergency nephrectomy which was not clear – it should not be either too early or too late. Unless we have a prospective management plan, the correct decision cannot be made. Radiologic risk stratification also alone would not do enough justice in evaluating the results as the clinical picture may not always correlate with the radiologic picture. Initial clinical presentation, clinical picture after resuscitation, comorbidities, and radiologic picture should be amalgamated to correctly stratify each patient and tailor the treatment accordingly. This will also help in comparing the results from different institutions. We created 3 risk groups based on the clinical condition, laboratory parameters, and radiological features. Even though the previous authors tailored treatment based on the general condition of the patient, this type of prospective risk group classification and treatment was not attempted by them.

The treatment and outcome correlated fairly well with the risk groups we have created. Among the patients who were categorized as risk Group 2, patients who had obstructive uropathy rapidly improved with DJ stenting. It appears that obstructive uropathy is a good prognostic factor as these patients are diagnosed earlier, and corrective measures could be undertaken earlier in the course of the disease. Among the patients who were categorized as risk Group 3, those who could be resuscitated and stabilized had recovered even though some of them required open drainage and emergency nephrectomy. It appears that patients who could not be stabilized despite aggressive resuscitation and PCD should be taken up for emergency nephrectomy as soon as possible. The mortality rate in our study was 4% (1 in 24). Three patients had emergency nephrectomy and all of them improved after surgery. The only patient who died in our study was a risk Group 3 patient who was referred to us in a very critical condition. The patient had such a rapid deterioration that she could not be adequately stabilized for taking up for emergency nephrectomy and succumbed despite PCD. Her diagnosis was delayed because of nonspecific presentation and delayed imaging. This underscores the importance of sensitizing the fellow specialties regarding the importance of this disease. The main problem with our study is the limited number of patients. However, at the same time, we must acknowledge the fact that a single center cannot get adequate number of patients to validate study in this group of patients, and further, the study should be initiated in other centers for a safer inference to be drawn.

   Conclusions Top

The clinical course of EPN can be changed with early identification, risk stratification, and aggressive management based on an active protocol-based treatment.

Financial support and sponsorship

Nil

Conflict of Interest

There are no conflicts of interest.

 

   References Top
1.Michaeli J, Mogle P, Perlberg S, Heiman S, Caine M. Emphysematous pyelonephritis. J Urol 1984;131:203-8.  Back to cited text no. 1
    2.Klein FA, Smith MJ, Vick CW 3rd, Schneider V. Emphysematous pyelonephritis: Diagnosis and treatment. South Med J 1986;79:41-6.  Back to cited text no. 2
    3.Ahlering TE, Boyd SD, Hamilton CL, Bragin SD, Chandrasoma PT, Lieskovsky G, et al. Emphysematous pyelonephritis: A 5-year experience with 13 patients. J Urol 1985;134:1086-8.  Back to cited text no. 3
    4.Somani BK, Nabi G, Thorpe P, Hussey J, Cook J, N'Dow J, et al. Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review. J Urol 2008;179:1844-9.  Back to cited text no. 4
    5.Kapoor R, Muruganandham K, Gulia AK, Singla M, Agrawal S, Mandhani A, et al. Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis. BJU Int 2010;105:986-9.  Back to cited text no. 5
    6.Aboumarzouk OM, Hughes O, Narahari K, Coulthard R, Kynaston H, Chlosta P, et al. Emphysematous pyelonephritis: Time for a management plan with an evidence-based approach. Arab J Urol 2014;12:106-15.  Back to cited text no. 6
    7.Aswathaman K, Gopalakrishnan G, Gnanaraj L, Chacko NK, Kekre NS, Devasia A. Emphysematous pyelonephritis: Outcome of conservative management. Urology 2008;71:1007-9.  Back to cited text no. 7
    8.Wan YL, Lee TY, Bullard MJ, Tsai CC. Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome. Radiology 1996;198:433-8.  Back to cited text no. 8
    9.Huang JJ, Tseng CC. Emphysematous pyelonephritis: Clinicoradiological classification, management, prognosis, and pathogenesis. Arch Intern Med 2000;160:797-805.  Back to cited text no. 9
    10.Mydlo JH, Maybee GJ, Ali-Khan MM. Percutaneous drainage and/or nephrectomy in the treatment of emphysematous pyelonephritis. Urol Int 2003;70:147-50.  Back to cited text no. 10
    11.Falagas ME, Alexiou VG, Giannopoulou KP, Siempos II. Risk factors for mortality in patients with emphysematous pyelonephritis: A meta-analysis. J Urol 2007;178:880-5.  Back to cited text no. 11
    12.Khaira A, Gupta A, Rana DS, Gupta A, Bhalla A, Khullar D. Retrospective analysis of clinical profile, prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis. Int Urol Nephrol 2009;41:959-66.  Back to cited text no. 12
    13.Kuo CY, Lin CY, Chen TC, Lin WR, Lu PL, Tsai JJ, et al. Clinical features and prognostic factors of emphysematous urinary tract infection. J Microbiol Immunol Infect 2009;42:393-400.  Back to cited text no. 13
    14.Ubee SS, McGlynn L, Fordham M. Emphysematous pyelonephritis. BJU Int 2011;107:1474-8.  Back to cited text no. 14
    15.Lin YC, Lin YC, Lin HD, Lin LY. Risk factors of renal failure and severe complications in patients with emphysematous pyelonephritis – A single-center 15-year experience. Am J Med Sci 2012;343:186-91.  Back to cited text no. 15
    16.Olvera-Posada D, García-Mora A, Culebro-García C, Castillejos-Molina R, Sotomayor M, Feria-Bernal G, et al. Prognostic factors in emphysematous pyelonephritis. Actas Urol Esp 2013;37:228-32.  Back to cited text no. 16
    17.Lu YC, Chiang BJ, Pong YH, Huang KH, Hsueh PR, Huang CY, et al. Predictors of failure of conservative treatment among patients with emphysematous pyelonephritis. BMC Infect Dis 2014;14:418.  Back to cited text no. 17
    18.Kelly HA. Pneumaturia MCWG. JAMA 1898;31:375-81.  Back to cited text no. 18
    19.Schultz EH Jr., Klorfein EH. Emphysematous pyelonephritis. J Urol 1962;87:762-6.  Back to cited text no. 19
    20.Gillies CL, Flocks R. Spontaneous renal and perirenal emphysema. Report of a case in a diabetic from Escherichia coli infection. Am J Roentgenol 1941;46:173.  Back to cited text no. 20
    21.Pontin AR, Barnes RD, Joffe J, Kahn D. Emphysematous pyelonephritis in diabetic patients. Br J Urol 1995;75:71-4.  Back to cited text no. 21
    22.Shokeir AA, El-Azab M, Mohsen T, El-Diasty T. Emphysematous pyelonephritis: A 15-year experience with 20 cases. Urology 1997;49:343-6.  Back to cited text no. 22
    23.Hudson MA, Weyman PJ, van der Vliet AH, Catalona WJ. Emphysematous pyelonephritis: Successful management by percutaneous drainage. J Urol 1986;136:884-6.  Back to cited text no. 23
    24.Koh KB, Lam HS, Lee SH. Emphysematous pyelonephritis: Drainage or nephrectomy? Br J Urol 1993;71:609-11.  Back to cited text no. 24
    25.Hall JR, Choa RG, Wells IP. Percutaneous drainage in emphysematous pyelonephritis – An alternative to major surgery. Clin Radiol 1988;39:622-4.  Back to cited text no. 25
    26.Corr J, Gleeson M, Wilson G, Grainger R. Percutaneous management of emphysematous pyelonephritis. Br J Urol 1993;71:487-8.  Back to cited text no. 26
    27.Zabbo A, Montie JE, Popowniak KL, Weinstein AJ. Bilateral emphysematous pyelonephritis. Urology 1985;25:293-6.  Back to cited text no. 27
    28.Nagappan R, Kletchko S. Bilateral emphysematous pyelonephritis resolving to medical therapy. J Intern Med 1992;232:77-80.  Back to cited text no. 28
    29.Grozel F, Berthezène Y, Guérin C, Tran-Minh VA, Croisille M. Bilateral emphysematous pyelonephritis resolving to medical therapy: Demonstration by US and CT. Eur Radiol 1997;7:844-6.  Back to cited text no. 29
    30.Wan YL, Lo SK, Bullard MJ, Chang PL, Lee TY. Predictors of outcome in emphysematous pyelonephritis. J Urol 1998;159:369-73.  Back to cited text no. 30
    31.Chen MT, Huang CN, Chou YH, Huang CH, Chiang CP, Liu GC. Percutaneous drainage in the treatment of emphysematous pyelonephritis: 10-year experience. J Urol 1997;157:1569-73.  Back to cited text no. 31
    32.Narlawar RS, Raut AA, Nagar A, Hira P, Hanchate V, Asrani A. Imaging features and guided drainage in emphysematous pyelonephritis: A study of 11 cases. Clin Radiol 2004;59:192-7.  Back to cited text no. 32
    33.Chan PH, Kho VK, Lai SK, Yang CH, Chang HC, Chiu B, et al. Treatment of emphysematous pyelonephritis with broad-spectrum antibacterials and percutaneous renal drainage: An analysis of 10 patients. J Chin Med Assoc 2005;68:29-32.  Back to cited text no. 33
    34.Derouiche A, Ouni A, Agrebi A, Slama A, Ben Slama MR, Chebil M. Management of emphysematous pyelonephritis based on a series of 21 cases. Prog Urol 2008;18:102-7.  Back to cited text no. 34
    35.El-Nahas AR, Shokeir AA, Eziyi AK, Barakat TS, Tijani KH, El-Diasty T, et al. Kidney preservation protocol for management of emphysematous pyelonephritis: Treatment modalities and follow-up. Arab J Urol 2011;9:185-9.  Back to cited text no. 35
    36.Ramanathan V, Nguyen PT, Van Nguyen P, Khan A, Musher D. Successful medical management of recurrent emphysematous pyelonephritis. Urology 2006;67:3.e11-3.  Back to cited text no. 36
    37.Kuchay MS, Laway BA, Bhat MA, Mir SA. Medical therapy alone can be sufficient for bilateral emphysematous pyelonephritis: Report of a new case and review of previous experiences. Int Urol Nephrol 2014;46:223-7.  Back to cited text no. 37
    38.Chi CH, Chen KW, Huang JJ, Chuang YC, Wu MH. Gas composition in Clostridium septicum gas gangrene. J Formos Med Assoc 1995;94:757-9.  Back to cited text no. 38
    39.Yang WH, Shen NC. Gas-forming infection of the urinary tract: An investigation of fermentation as a mechanism. J Urol 1990;143:960-4.  Back to cited text no. 39
    40.Huang JJ, Chen KW, Ruaan MK. Mixed acid fermentation of glucose as a mechanism of emphysematous urinary tract infection. J Urol 1991;146:148-51.  Back to cited text no. 40
    

 
 


  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7], [Table 8]
  Top

留言 (0)

沒有登入
gif